Quest Diagnostics (DGX) Change in Accured Expenses (2016 - 2026)
Quest Diagnostics' Change in Accured Expenses history spans 18 years, with the latest figure at -$12.0 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 77.36% to -$12.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $170.0 million, a 431.25% increase, with the full-year FY2025 number at $129.0 million, up 292.54% from a year prior.
- Change in Accured Expenses hit -$12.0 million in Q1 2026 for Quest Diagnostics, down from $16.0 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for DGX hit a ceiling of $176.0 million in Q4 2023 and a floor of -$211.0 million in Q1 2023.
- Historically, Change in Accured Expenses has averaged -$9.1 million across 5 years, with a median of $16.0 million in 2025.
- Biggest five-year swings in Change in Accured Expenses: surged 2100.0% in 2022 and later tumbled 334.38% in 2023.
- Tracing DGX's Change in Accured Expenses over 5 years: stood at $20.0 million in 2022, then soared by 780.0% to $176.0 million in 2023, then tumbled by 80.11% to $35.0 million in 2024, then plummeted by 54.29% to $16.0 million in 2025, then plummeted by 175.0% to -$12.0 million in 2026.
- Business Quant data shows Change in Accured Expenses for DGX at -$12.0 million in Q1 2026, $16.0 million in Q4 2025, and $124.0 million in Q3 2025.